JP2022526408A5 - - Google Patents
Info
- Publication number
- JP2022526408A5 JP2022526408A5 JP2021559096A JP2021559096A JP2022526408A5 JP 2022526408 A5 JP2022526408 A5 JP 2022526408A5 JP 2021559096 A JP2021559096 A JP 2021559096A JP 2021559096 A JP2021559096 A JP 2021559096A JP 2022526408 A5 JP2022526408 A5 JP 2022526408A5
- Authority
- JP
- Japan
- Prior art keywords
- day
- combination according
- cells
- receptor agonist
- approximately
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025050426A JP2025089477A (ja) | 2019-04-05 | 2025-03-25 | 細胞免疫療法を増強するための方法 |
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962830212P | 2019-04-05 | 2019-04-05 | |
| US62/830,212 | 2019-04-05 | ||
| US201962861858P | 2019-06-14 | 2019-06-14 | |
| US62/861,858 | 2019-06-14 | ||
| US201962898473P | 2019-09-10 | 2019-09-10 | |
| US62/898,473 | 2019-09-10 | ||
| US201962944955P | 2019-12-06 | 2019-12-06 | |
| US62/944,955 | 2019-12-06 | ||
| PCT/US2020/026778 WO2020206395A1 (en) | 2019-04-05 | 2020-04-04 | Method for enhancing cellular immunotherapy |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025050426A Division JP2025089477A (ja) | 2019-04-05 | 2025-03-25 | 細胞免疫療法を増強するための方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022526408A JP2022526408A (ja) | 2022-05-24 |
| JP2022526408A5 true JP2022526408A5 (enExample) | 2023-04-06 |
| JP7672342B2 JP7672342B2 (ja) | 2025-05-07 |
Family
ID=72666293
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021559096A Active JP7672342B2 (ja) | 2019-04-05 | 2020-04-04 | 細胞免疫療法を増強するための方法 |
| JP2025050426A Pending JP2025089477A (ja) | 2019-04-05 | 2025-03-25 | 細胞免疫療法を増強するための方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025050426A Pending JP2025089477A (ja) | 2019-04-05 | 2025-03-25 | 細胞免疫療法を増強するための方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20230158164A1 (enExample) |
| EP (1) | EP3946426A4 (enExample) |
| JP (2) | JP7672342B2 (enExample) |
| KR (1) | KR20210149090A (enExample) |
| CN (1) | CN113677362A (enExample) |
| AU (2) | AU2020252569B2 (enExample) |
| CA (1) | CA3134539A1 (enExample) |
| IL (1) | IL286971B1 (enExample) |
| MX (1) | MX2021012236A (enExample) |
| WO (1) | WO2020206395A1 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20250082777A1 (en) | 2022-01-10 | 2025-03-13 | Sana Biotechnology, Inc. | Methods of ex vivo dosing and administration of lipid particles or viral vectors and related systems and uses |
| WO2023193015A1 (en) | 2022-04-01 | 2023-10-05 | Sana Biotechnology, Inc. | Cytokine receptor agonist and viral vector combination therapies |
| WO2024215987A1 (en) * | 2023-04-14 | 2024-10-17 | Sotio Biotech Inc. | IMMUNE CELLS FOR TREATING CANCER IN COMBINATION WITH IL-15/IL-15Rα CONJUGATES |
| EP4694916A1 (en) * | 2023-04-14 | 2026-02-18 | SOTIO Biotech Inc. | Engineered immune cells for treating cancer in combination with il-2/il-15 receptor ?? agonists |
| WO2025191133A1 (en) | 2024-03-15 | 2025-09-18 | Avidicure Ip B.V. | Il-21 muteins, fusion proteins comprising the same and uses thereof |
| WO2025191136A1 (en) | 2024-03-15 | 2025-09-18 | Avidicure Ip B.V. | Muteins of 4-1bb ligand extracellular domain, fusion proteins comprising the same and uses thereof |
| WO2025264864A1 (en) * | 2024-06-18 | 2025-12-26 | Fred Hutchinson Cancer Center | Human anti-cd45 antibodies and uses thereof |
| WO2026087748A1 (en) | 2024-10-24 | 2026-04-30 | Avidicure Ip B.V. | Multispecific antigen binding proteins for the expansion of γδ t cells and use thereof |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3049652A1 (en) * | 2017-01-10 | 2018-07-19 | Intrexon Corporation | Modulating expression of polypeptides via new gene switch expression systems |
| CN108728459B (zh) * | 2017-04-24 | 2023-08-04 | 上海恒润达生生物科技股份有限公司 | 靶向cd19的嵌合抗原受体并联合表达il-15的方法和用途 |
| KR20250057110A (ko) * | 2017-05-15 | 2025-04-28 | 넥타르 테라퓨틱스 | 지속 작용성 인터류킨-15 수용체 효현제 및 관련 면역요법 조성물 및 방법 |
| US12350312B2 (en) * | 2017-09-06 | 2025-07-08 | Fred Hutchinson Cancer Center | Methods for improving adoptive cell therapy |
-
2020
- 2020-04-04 IL IL286971A patent/IL286971B1/en unknown
- 2020-04-04 JP JP2021559096A patent/JP7672342B2/ja active Active
- 2020-04-04 WO PCT/US2020/026778 patent/WO2020206395A1/en not_active Ceased
- 2020-04-04 MX MX2021012236A patent/MX2021012236A/es unknown
- 2020-04-04 AU AU2020252569A patent/AU2020252569B2/en active Active
- 2020-04-04 EP EP20782166.1A patent/EP3946426A4/en active Pending
- 2020-04-04 CA CA3134539A patent/CA3134539A1/en active Pending
- 2020-04-04 US US17/601,611 patent/US20230158164A1/en active Pending
- 2020-04-04 CN CN202080026218.8A patent/CN113677362A/zh active Pending
- 2020-04-04 KR KR1020217034537A patent/KR20210149090A/ko active Pending
-
2025
- 2025-03-25 JP JP2025050426A patent/JP2025089477A/ja active Pending
-
2026
- 2026-04-08 AU AU2026202632A patent/AU2026202632A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7770929B2 (ja) | Ｃａｒ－ｔ細胞のインサイチュ動員、リプログラミングおよび放出 | |
| US12053523B2 (en) | Compositions comprising chemotherapeutic agents and checkpoint inhibitors and methods of use | |
| JP2019534308A5 (enExample) | ||
| JP7470988B2 (ja) | 生物応答性ヒドロゲルマトリックス及び使用方法 | |
| JP2016533344A5 (enExample) | ||
| JP2021534101A5 (enExample) | ||
| JP2023531122A (ja) | 材料足場を使用した哺乳類細胞の増強されたウイルス形質導入 | |
| JP2010515748A5 (enExample) | ||
| CN112135639B (zh) | 细胞组装介导的癌症免疫治疗检查点抑制剂的递送 | |
| JP2022526408A (ja) | 細胞免疫療法を増強するための方法 | |
| WO2023063242A1 (ja) | ＩＦＮ－γへ選択的に結合するオリゴヌクレオチドを含有する自己免疫性疾患治療薬およびそのオリゴヌクレオチド | |
| JP7579570B2 (ja) | 術後治療用ｉｎ ｓｉｔｕ噴霧生体応答性免疫療法ゲル | |
| US20220370496A1 (en) | Her3 pulsed dc1 therapy | |
| US20250163418A1 (en) | Brush polymer-oligonucleotide conjugates for the treatment of muscular dystrophy | |
| Zhang et al. | ATP-responsive and functionalized framework nucleic acid for synergistic radio-immunotherapy | |
| JP2025535807A (ja) | 移植可能な足場材料及び使用方法 | |
| EP3153155A1 (en) | Refillable drug delivery devices and methods of use thereof | |
| WO2022076523A1 (en) | Methods and compositions for imaging and treating cancer | |
| WO2020160409A1 (en) | Methods of treating cancer using a combination of tumor membrane vesicles and metformin | |
| US20230257463A1 (en) | In situ thiol-maleimide crosslinked hydrogel for immune checkpoint blockade delivery | |
| WO2026015886A1 (en) | Polymer matrix delivery system for delivering cancer adjuvant and implant comprising same | |
| CN121910648A (zh) | 一种鼻腔递送双链RNA/Mn2+纳米药物及其制备方法与在免疫治疗中的应用 | |
| CN113995750A (zh) | 基于维生素c水凝胶的肿瘤免疫治疗用药物组合物 |